Tuesday, 20 October 2026European Markets

AERKOMM INC Stock Is 21% Down So Far Today

Loading stream...

(vianews) - shares of aerkomm inc (cac 40: akom.pa) dropped by a staggering 21.67% to €3.18 at 13:40 est on tuesday, after five sequential sessions in a row of losses. cac 40 is jumping 0.49% to €7,243.72, following the last session's upward trend. this seems, so far, a somewhat bullish trend trading session today.

about aerkomm inc

aerkomm inc., together with its subsidiaries, focuses on providing in-flight entertainment and connectivity solutions in the asian pacific region. the company intends to offer airline passengers with broadband in-flight service options, such as wi-fi, cellular, movies, gaming, live tv, and music through built-in in-flight entertainment systems, such as seat-back displays, as well as on passengers' personal devices. it also focuses on providing content management services and e-commerce solutions; and aerkomm k++ system, a ifec system. the company is based in fremont, california.

earnings per share

as for profitability, aerkomm inc has a trailing twelve months eps of €-0.794.

more news about aerkomm inc (akom.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Sovereign, Local and Open AI: Infrastructure and Applied Intelligence Scale Up While Frontier-Lab Safety Scrutiny Grows
AI is shifting from cloud-rented models toward locally run, owned and open intelligence. ASUS/NVIDIA RTX Spark laptops pair with Nous Research's Hermes and ComfyUI, and Microsoft pushes hybrid local/cloud Windows. Cisco, NVIDIA and Marvell build open high-bandwidth AI infrastructure, and Hesai supplies real-world data for physical AI. In finance and commerce, Intuit, Zeta, Parloa/TELUS Digital and Snipp embed agentic AI into trusted financial and customer workflows, while OpenAI's math breakthroughs, its security disclosures and an executive's departure from its safety role keep safety and governance scrutiny high.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,404 source documents archived
Query this data → isubstrate.com